| #1 |
|
Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
Article in Glycobiology, September 2008
|
| #2 |
|
Human milk oligosaccharides: Every baby needs a sugar mama
Article in Glycobiology, April 2012
|
| #3 |
|
Global aspects of viral glycosylation
Article in Glycobiology, March 2018
|
| #4 |
|
Biological roles of glycans
Article in Glycobiology, August 2016
|
| #5 |
|
Developments and perspectives in high-throughput protein glycomics: enabling the analysis of thousands of samples
Article in Glycobiology, April 2022
|
| #6 |
|
Sweating the small stuff: Glycoproteins in human sweat and their unexplored potential for microbial adhesion
Article in Glycobiology, November 2015
|
| #7 |
|
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2
Article in Glycobiology, May 2020
|
| #8 |
|
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
Article in Glycobiology, October 2020
|
| #9 |
|
Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG
Article in Glycobiology, August 2007
|
| #10 |
|
A periodic table of monosaccharides
Article in Glycobiology, November 2023
|
| #11 |
|
Cancer glycan epitopes: biosynthesis, structure and function
Article in Glycobiology, March 2018
|
| #12 |
|
A refined palate: Bacterial consumption of host glycans in the gut
Article in Glycobiology, May 2013
|
| #13 |
|
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication
Article in Glycobiology, September 2020
|
| #14 |
|
The role of cell surface sialic acids for SARS-CoV-2 infection
Article in Glycobiology, April 2021
|
| #15 |
|
Updates to the Symbol Nomenclature for Glycans guidelines
Article in Glycobiology, June 2019
|
| #16 |
|
Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes
Article in Glycobiology, September 2013
|
| #17 |
|
Fc glycans of therapeutic antibodies as critical quality attributes
Article in Glycobiology, August 2015
|
| #18 |
|
Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family
Article in Glycobiology, December 2011
|
| #19 |
|
Glycoengineered antibodies: towards the next-generation of immunotherapeutics
Article in Glycobiology, October 2018
|
| #20 |
|
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution
Article in Glycobiology, May 2007
|
